Tested a new medicine to reduce diabetic nerve pain
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and sign informed consent to join the study
- Have diabetes (type 1 or type 2) for at least 1 year, and keep your diabetes medicines the same for the last 3 months
- Have painful diabetic nerve damage in your legs/feet, with at least numbness or tingling (or related nerve pain) plus nerve-related exam findings
- Have moderate to severe pain: LANSS score of 12 or higher and a 0–10 pain score of 4 or higher, with enough diary entries (at least 4 of 7 days)
- Have recent blood sugar control that fits the study (HbA1c 11% or lower)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
This trial tests a drug called glibenclamide, commonly used for diabetes, to see if it can reduce nerve pain in people with multiple sclerosis. If you join, you will receive the drug or a placebo (inactive treatment) and your pain levels will be monitored.
This study tests whether a nerve pain medication (pregabalin) helps people with long-term nerve pain sleep better. It involves brain scans to see how the medication affects the brain.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This study tests an investigational medicine (HL-1186) to see if it can reduce nerve pain caused by diabetes. If you have had burning or shooting pain in your feet or legs for at least 6 months, this trial might help find a new way to ease that pain.
This trial tests if Levagen+ (a supplement) can reduce nerve pain caused by diabetes. It is for people with type 1 or type 2 diabetes who have significant nerve pain in their feet or legs.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.